HARBIN GLORIA PHARMACEUTICALS Co., LTD (SHE:002437)

Market Cap	5.57B
Revenue (ttm)	2.40B
Net Income (ttm)	240.73M
Shares Out	2.25B
EPS (ttm)	0.11
PE Ratio	23.41
Forward PE	24.80
Dividend	n/a
Ex-Dividend Date	n/a

Volume	42,808,500
Average Volume	92,889,161
Open	2.500
Previous Close	2.500
Day's Range	2.470 - 2.590
52-Week Range	1.660 - 2.990
Beta	0.40
RSI	50.30
Earnings Date	Apr 26, 2025

About SHE:002437

Harbin Gloria Pharmaceuticals Co., Ltd engages in the research, development, production, and sale of pharmaceutical products primarily in the People’s Republic of China. It offers cardiac cerebrovascular medication, skeletal muscle system, vitamins and minerals, urinary system medication, antitumor medication, endocrine medicine, anti-infective drugs, respiratory medication, antihistamine, peptic, and other products. Harbin Gloria Pharmaceuticals Co., Ltd was founded in 2000 and is based in Harbin, the People’s Republic of China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2000
• Employees: 3,085
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002437

Financial Performance

In 2024, SHE:002437's revenue was 2.44 billion, a decrease of -7.06% compared to the previous year's 2.63 billion. Earnings were 232.76 million, an increase of 93.43%.